Oseltamivir Phosphate capsules
Contract number CW2236377
Solicitation number WS3541373832
Contract award date
Expiry date
Amendment date
Amendment value CAD 133,085.00
Contract details
This contract was awarded to:
Natco Pharma (Canada) Inc.
antivirals for influenza
- Business address
-
2000 Argentia Rd Plaza 1, Suite 200Mississauga, Ontario, L5N 1P7CA
- Notice type
- Request for Proposal
- Procurement method
- Competitive – Open Bidding
- Language(s)
-
English,French
- Selection criteria
- Lowest Price
- Region(s) of delivery
-
AlbertaBritish ColumbiaManitobaNew BrunswickNational Capital Region (NCR)Newfoundland and LabradorNova ScotiaNorthwest TerritoriesOntario (except NCR)Prince Edward IslandQuebec (except NCR)
Contract duration
The contract will be for a period of 30 month(s), from 2022/09/14 to 2025/03/31.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 21,530,809.65
Commodity - UNSPSC
- 51000000 - Drugs and Pharmaceutical Products
Trade agreements
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-Colombia Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Ukraine Free Trade Agreement (CUFTA)
-
Canadian Free Trade Agreement (CFTA)
-
Canada-Honduras Free Trade Agreement
-
Canada-Panama Free Trade Agreement
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
None
Contact information
Contracting organization
- Organization
-
Department of Public Works and Government Services (PSPC)
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Joy, Sharon (SPAC/PSPC)
- Email
- sharon.joy@tpsgc-pwgsc.gc.ca
Buying organization(s)
Related notices
Amendments made to this contract (3) A total of 3 amendments have been made to this contract. Click to collapse
This is a list of the amendments made to contract
CW2236377 that is awarded to Natco Pharma (Canada) Inc..
Amendment number
|
Contract value
|
Award date
|
|---|---|---|
| 002 | CAD 21 530 809.65 | 2022/09/14 |
| 001 | CAD 21 530 809.65 | 2022/09/14 |
| 000 | CAD 21 530 809.65 | 2022/09/14 |
Tender notices (1) This contract has 1 related tender notices. Click to collapse
|
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| Oseltamivir Phosphate Capsules | WS3541373832 | 2022/07/19 | 2022/08/10 |
Contracts awarded (1) This contract has 1 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number WS3541373832. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| Natco Pharma (Canada) Inc. | CW2236377 | 2024/04/17 | 2022/09/14 | Viewthe details of contract CW2236377 for Natco Pharma (Canada) Inc. |
Contract history (3) This contract has 3 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment number
|
Award date
|
More details |
|---|---|---|---|---|
| Natco Pharma (Canada) Inc. | CW2236377 | 002 | 2022/09/14 | Viewthe details of contract CW2236377 for Natco Pharma (Canada) Inc. |
| Natco Pharma (Canada) Inc. | CW2236377 | 001 | 2022/09/14 | Viewthe details of contract CW2236377 for Natco Pharma (Canada) Inc. |
| Natco Pharma (Canada) Inc. | CW2236377 | 000 | 2022/09/14 | Viewthe details of contract CW2236377 for Natco Pharma (Canada) Inc. |
